Skip to main content
. 1998 Jul;66(7):3134–3141. doi: 10.1128/iai.66.7.3134-3141.1998

TABLE 1.

Strains and plasmids used in this study

Strain or plasmid Relevant characteristic(s)a Reference or source
V. vulnificus strains
 CML17 80363 Δ(fur) 28
 MO6-24 Polyr, opaque 55
 CML49 MO6-24, Δ(hupA) This study
E. coli strains
 DH5α FendA1 hsdR17 supE44 thi-1 recA1 gyrA96 relA1 Δ(argF-lacZYA)U169 (φ80ΔlacZ M15)λ 18
 ABLE K lac(LacZ) [Kanr McrA McrCB McrA McrF Mrr HsdR (rK mK)] [F′ proAB lacIqZΔ M15 Tn10 (Tetr)] Stratagene
 SY327λpir Δ(lac pro) nalA recA56 araD argE(Am) λpir R6K 30
 SM10λpir thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu λpir R6K Kmr 30
Plasmids
 pUC19 Cloning vector; Apr Laboratory stock
 pBluescript SK Phagemid derived from pUC19; Apr Stratagene
 pLAFR3 Cloning vector; Tcr 48
 pCML37 V. vulnificus hupA clone from V. vulnificus MO6-24 genomic library; 8-kbp chromosomal fragment in pBluescript SK; Apr This study
 pCML38 1.7-kbp HindIII V. vulnificus hupA clone in pBluescript SK; Apr This study
 pCML40 pBluescript SK with HindIII insertion of V. vulnificus hupA, containing an internal 567-bp BglII-EspI deletion; Apr This study
 pCVD442 Positive selection suicide vector, pGP704 with sacB gene inserted in multiple cloning site; Apr 10
 pCML41 pCVD442 with HindIII insertion of V. vulnificus hupA, containing an internal 567-bp BglII-EspI deletion; Apr This study
 pCML42 2.3-kbp NcoI-BamHI hupA fragment and pBluescript cloned into the BamHI site of pLAFR3; Tcr Apr This study
a

Apr, ampicillin resistance; Kmr, kanamycin resistance; Polyr, polymyxin B resistance; Tcr, tetracycline resistance.